What is MRNA's market capitalization?

Moderna has a market capitalization of $19.68B.

Does MRNA pay a dividend?

Moderna does not currently pay a dividend, or dividend data is unavailable. Many growth-oriented companies reinvest profits rather than paying dividends.

What is MRNA's earnings per share (EPS)?

Moderna's trailing twelve-month earnings per share (EPS) is -$12.33. EPS measures the portion of company profit allocated to each outstanding share of stock.

MRNA

NASDAQ

Moderna

Price unavailable — configure POLYGON_API_KEY

Overview Earnings Dividends IR

Key Statisticslimited data

Market Cap$19.68B

P/E RatioN/A

Div. Yield—

EPS (TTM)-$12.33

52W High—

52W Low—

SectorHealth Care

Industry—

Employees4,700

Price Performance

1 Week-0.73%

3 Month+52.94%

1 Year+91.22%

FinancialsAnnual · QuiverQuant

Revenue$6.85B

Assets$18.43B

Liabilities$4.57B

Net Income$4.71B loss

About

Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.

Company Info

CAMBRIDGE, MA

4,700 employees

Listed 2018-12-07

biological products, (no diagnostic substances)

www.modernatx.com

📞(617) 714-6500

WebullFree stocks

Advanced charting, extended hours trading, and free stock for new accounts.

Open Account

Analyze MRNA with professional charts— Free to start

Price data sourced from Polygon.io (previous trading day close). Fundamentals from Alpha Vantage. Insider trades from SEC EDGAR. Cached via Cloudflare KV.